Question 1

What specific combinations of treatments will I receive if I participate?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the An Investigational Immuno-therapy Study of Nivolumab, Pomalidomide and Dexamethasone Combinations in Patients With Multiple Myeloma clinical trial (NCT02726581). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this trial compare to other treatment options I have?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the An Investigational Immuno-therapy Study of Nivolumab, Pomalidomide and Dexamethasone Combinations in Patients With Multiple Myeloma clinical trial (NCT02726581). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential side effects of the treatments in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the An Investigational Immuno-therapy Study of Nivolumab, Pomalidomide and Dexamethasone Combinations in Patients With Multiple Myeloma clinical trial (NCT02726581). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to come in for treatment and monitoring?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the An Investigational Immuno-therapy Study of Nivolumab, Pomalidomide and Dexamethasone Combinations in Patients With Multiple Myeloma clinical trial (NCT02726581). Contact the study team or your healthcare provider for specific answers.

Question 5

What tests or procedures will I need to undergo during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the An Investigational Immuno-therapy Study of Nivolumab, Pomalidomide and Dexamethasone Combinations in Patients With Multiple Myeloma clinical trial (NCT02726581). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any travel or logistical considerations I should be aware of?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the An Investigational Immuno-therapy Study of Nivolumab, Pomalidomide and Dexamethasone Combinations in Patients With Multiple Myeloma clinical trial (NCT02726581). Contact the study team or your healthcare provider for specific answers.

What this study is about